After autologous CAR-T cell therapies, patient 1 with mycosis fungoides achieved PR on day 65, relapsed on day 180 and attained CR followed by 11-fraction radiotherapy; patients 2 and 3 suffered CD7+ relapses on day 103 and 140, respectively. This evidence concerns the gene CD7 and mycosis fungoides.